SUN’IY INTELLEKT VA NEVROLOGIYA: NEYRODEGENERATIV KASALLIKLARNI ERTA TASHXISLASHNING ZAMONAVIY YONDASHUVLARI (ADABIYOTLAR SHARHI)
DOI:
https://doi.org/10.5281/zenodo.23757548Keywords:
sun’iy intellekt, nevrologiya, Altsgeymer kasalligi, Parkinson kasalligi, mashinaviy o‘rganish, chuqur o‘rganish, magnit-rezonans tomografiya, erta tashxis, shaxsiylashtirilgan tibbiyot, tibbiy diagnostikaAbstract
Ushbu maqolada sun’iy intellekt texnologiyalarining nevrologik kasalliklarni erta aniqlash, tashxislash, kasallik kechishini prognozlash va davolash jarayonini takomillashtirishdagi imkoniyatlari ilmiy adabiyotlar asosida tahlil qilinadi. Xususan, Altsgeymer kasalligi, Parkinson kasalligi va boshqa asab tizimi kasalliklarini o‘rganishda mashinaviy o‘rganish, chuqur o‘rganish, tibbiy tasvirlarni avtomatik tahlil qilish hamda turli klinik ma’lumotlarni birgalikda qayta ishlash usullariga e’tibor qaratiladi. Shuningdek, sun’iy intellektdan foydalanishda ma’lumotlar sifati, algoritmlarning ishonchliligi, tashqi tekshiruv zarurati, bemorlarning shaxsiy ma’lumotlarini himoya qilish va tibbiy qarorlar uchun mas’uliyat kabi muammolar ko‘rib chiqiladi. Adabiyotlar tahlili sun’iy intellekt nevrologik kasalliklarni aniqlash va bemorlarni kuzatishda istiqbolli yordamchi vosita ekanini, biroq uning klinik amaliyotdagi samaradorligi yetarli tekshiruv, shaffoflik va shifokor nazorati bilan ta’minlanishi lozimligini ko‘rsatadi.References
1. Voigtlaender, S., Pawelczyk, J., Geiger, M., et al. (2024). Artificial intelligence in neurology: opportunities, challenges, and policy implications. Journal of Neurology, 271(5), 2258–2273. https://doi.org/10.1007/s00415-024-12220-8
2. Myszczynska, M. A., Ojamies, P. N., Lacoste, A. M. B., et al. (2020). Applications of machine learning to diagnosis and treatment of neurodegenerative diseases. Nature Reviews Neurology, 16, 440–456. https://doi.org/10.1038/
3. Borchert, R. J., Azevedo, T., Badhwar, A., et al. (2023). Artificial intelligence for diagnostic and prognostic neuroimaging in dementia: A systematic review. Alzheimer’s & Dementia, 19(12), 5885–5904. https://doi.org/10.1002/alz.13412
4. World Health Organization. Ethics and Governance of Artificial Intelligence for Health: WHO Guidance. Geneva: World Health Organization; 2021. ISBN: 978-92-4-002920-0.
5. Feng, T. (2023). Applications of Artificial Intelligence to Diagnosis of Neurodegenerative Diseases. Studies in Health Technology and Informatics. 2023. DOI: 10.3233/SHTI230896. https://doi.org/10.3233/SHTI230896
6. Yousefi va hammualliflar. Machine Learning Based Algorithms for Virtual Early Detection and Screening of Neurodegenerative and Neurocognitive Disorders: A Systematic Review. Frontiers in Neurology. 2024. DOI: 10.3389/fneur.2024.1413071.
7. U.S. Food and Drug Administration. Artificial Intelligence-Enabled Medical Devices. Available at: https://www. fda.gov/medical-devices/digital-health-center-excellence/artificial-intelligence-enabled-medical-devices.
8. Litjens, G., Kooi, T., Bejnordi, B. E., et al. (2017). A survey on deep learning in medical image analysis. Medical Image Analysis, 42, 60–88. https://doi.org/10.1016/j.media.2017.07.005
9. LeCun, Y., Bengio, Y., & Hinton, G. (2015). Deep learning. Nature, 521, 436–444. https://doi.org/10.1038/nature14539
10. Vasey, B., Nagendran, M., Campbell, B., et al. (2022). Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI. Nature Medicine, 28, 924–933. https://doi.org/10.1038/s41591-022-01772-9
11. Liu, X. (2020). Cruz Rivera S, Moher D, et al. Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: The CONSORT-AI extension. Nature Medicine, 26, 1364–1374. https://doi.org/10.1038/
12. Frizzell, T. O., Glashutter, M., Liu, C. C., et al. (2022). Artificial intelligence in brain MRI analysis of Alzheimer’s disease over the past 12 years: A systematic review. Ageing Research Reviews. 2022;77:101614. DOI: 10.1016/j. arr.2022.101614. https://doi.org/10.1016/j
13. Ahmadzadeh, M., Christie, G. J., Cosco, T. D., et al. (2023). Neuroimaging and machine learning for studying the pathways from mild cognitive impairment to Alzheimer’s disease: A systematic review. BMC Neurology. 2023;23:309. DOI: 10.1186/s12883-023-03323-2. 12883–023. https://doi.org/10.1186/s12883-023-03323-2
14. Odusami, M., Maskeliūnas, R., Damaševičius, R., et al. (2024). Machine learning with multimodal neuroimaging data to classify stages of Alzheimer’s disease: A systematic review and meta-analysis. Cognitive Neurodynamics, 18, 775–794. https://doi.org/10.1007/s11571-023-09993-5
15. Bose, D., Mukherjee, A., Acharya, M., et al. (2025). Artificial Intelligence for Detection of Parkinson’s Disease From Speech Signals—A Comprehensive Review. BioFactors. 2025;51(6):e70065. DOI: 10.1002/biof.70065. https://doi.org/10.1002/biof.70065
16. Machine Learning Applications for Diagnosing Parkinson’s Disease via Speech, Language, and Voice Changes: A Systematic Review. Inventions. 2025;10(4):48. DOI: 10.3390/inventions10040048.
17. Endrizzi, W., Ragni, F., Bovo, S., et al. (2026). The landscape of artificial intelligence in neurodegenerative diseases: a systematic review. Communications Medicine. 2026. DOI: 10.1038/s43856-026-01669-5. 43856–026. https://doi.org/10.1038/s43856-026-01669-5
18. Dantas, J., Ribeiro, G., Dagostin, C., et al. (2024). Can Artificial Intelligence to Detect Large Vessel Occlusion Improve Patient Care? A Systematic Review and Meta-analysis. Neurology. 2024;102(7 Supplement 1):6072. DOI: 10.1212/WNL.0000000000206218. https://doi.org/10.1212/WNL.0000000000206218
19. EEG-Based Epileptic Seizure Detection via Machine/Deep Learning Approaches: A Systematic Review. 2022. DOI: 10.1155/2022/6486570.
20. Machine and deep learning methods for epileptic seizure recognition using EEG data: A systematic review. Brain Research. 2025;1864:149797. DOI: 10.1016/j.brainres.2025.149797.
21. Topol, E. J. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25, 44–56. https://doi.org/10.1038/s41591-018-0300-7
22. Wiens, J., Saria, S., Sendak, M., et al. (2019). Do no harm: a roadmap for responsible machine learning for health care. Nature Medicine, 25, 1337–1340. https://doi.org/10.1038/s41591-019-0548-6
23. Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019;366(6464):447–453. DOI: 10.1126/science.aax2342.
24. The CONSORT-AI and SPIRIT-AI Steering Group. Reporting guidelines for clinical trials evaluating artificial intelligence interventions are needed. Nature Medicine. 2019;25:1467–1468. DOI: 10.1038/s41591-019-0603-3.
25. Collins, G. S., Moons, K. G. M., Dhiman, P., et al. (2024). TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ. 2024;385:e078378. DOI: 10.1136/bmj-2023-078378. https://doi.org/10.1136/bmj-2023-078378
26. Abdumanonov, A. A., & Ruziev, Sh. I. (2022). Artificial Intelligence in Medical Diagnostics. Acta CAMU, 1, 54–62. https://doi.org/10.5281/zenodo.7578352
27. Vikhrov, I., Pardaev, S., & Kadirova, M. (2022). Publication Activity of Central Asian Scientists on Artificial Intelligence Including Medicine. Interdisciplinary Approaches to Medicine, 3(1), 72–77. https://doi.org/10.26577/IAM.2022
28. Khodjibekov, M., Khodjibekova, Y., & Yunusova, L. (2026). Building the Future of Radiology Through Artificial Intelligence: Uzbekistan National Efforts and Innovations. Korean Journal of Radiology, 27(2), 91–93. https://doi.org/10.3348/kjr.2025.1550

